On November 13th EyeOn hosted an idea lab on the impact of MDR (medical device regulation) on supply chain planning processes in Brussels, Belgium.
After a brief clarification on the new EU MDR regulations and an introduction on the planning impact, participants discussed the elements to consider from a supply planning perspective.
Regulatory aspects, timing of registrations, portfolio review, integration of MDR changes in the S&OP cycle, master data management, demand and supply risks were some of the topics that were considered as points of attention for a proper supply chain integration of MDR regulations.
Participants confirmed the impact of MDR on supply chain planning is severely underestimated and emphasized MDR is more than a QA/RA topic.
MDR really needs to be addressed cross departmental with senior management attention on systematic risk review.
Please find a selection of slides here.
For more information about MDR and its impact on planning you can contact Luc van Wouwe, or Loek Lemmens.